BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 23943493)

  • 1. Purinergic signalling in the musculoskeletal system.
    Burnstock G; Arnett TR; Orriss IR
    Purinergic Signal; 2013 Dec; 9(4):541-72. PubMed ID: 23943493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of purinergic signalling in the musculoskeletal system.
    Orriss IR
    Auton Neurosci; 2015 Sep; 191():124-34. PubMed ID: 25979767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinoceptor expression in regenerating skeletal muscle in the mdx mouse model of muscular dystrophy and in satellite cell cultures.
    Ryten M; Yang SY; Dunn PM; Goldspink G; Burnstock G
    FASEB J; 2004 Sep; 18(12):1404-6. PubMed ID: 15231720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of osteoblast function and bone mineralisation by extracellular nucleotides: The role of p2x receptors.
    Orriss IR; Key ML; Brandao-Burch A; Patel JJ; Burnstock G; Arnett TR
    Bone; 2012 Sep; 51(3):389-400. PubMed ID: 22749889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic signalling and bone remodelling.
    Orriss IR; Burnstock G; Arnett TR
    Curr Opin Pharmacol; 2010 Jun; 10(3):322-30. PubMed ID: 20189453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular ATP signaling and clinical relevance.
    Dou L; Chen YF; Cowan PJ; Chen XP
    Clin Immunol; 2018 Mar; 188():67-73. PubMed ID: 29274390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation.
    Orriss IR; Key ML; Hajjawi MO; Arnett TR
    PLoS One; 2013; 8(7):e69057. PubMed ID: 23874866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pannexin 3 channels in health and disease.
    O'Donnell BL; Penuela S
    Purinergic Signal; 2021 Dec; 17(4):577-589. PubMed ID: 34250568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic signalling: past, present and future.
    Burnstock G
    Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides.
    Dubyak GR; el-Moatassim C
    Am J Physiol; 1993 Sep; 265(3 Pt 1):C577-606. PubMed ID: 8214015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular nucleotides and nucleosides as signalling molecules.
    Giuliani AL; Sarti AC; Di Virgilio F
    Immunol Lett; 2019 Jan; 205():16-24. PubMed ID: 30439478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to Purinergic Signaling.
    Burnstock G
    Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of purinergic receptor polymorphisms in human bone.
    Wesselius A; Bours MJ; Agrawal A; Gartland A; Dagnelie PC; Schwarz P; Jorgensen NR
    Front Biosci (Landmark Ed); 2011 Jun; 16(7):2572-85. PubMed ID: 21622196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic signalling: from normal behaviour to pathological brain function.
    Burnstock G; Krügel U; Abbracchio MP; Illes P
    Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic signalling: pathophysiology and therapeutic potential.
    Burnstock G
    Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction to Purinergic Signalling in the Brain.
    Burnstock G
    Adv Exp Med Biol; 2020; 1202():1-12. PubMed ID: 32034706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinergic signalling: what is missing and needed next? The use of transgenic mice, crystallographic analysis and MicroRNA.
    Volonté C; Parisi C; Burnstock G
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):751-67. PubMed ID: 22963439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic receptors in skeletal muscles in health and in muscular dystrophy.
    Krasowska E; Róg J; Sinadinos A; Young CN; Górecki DC; Zabłocki K
    Postepy Biochem; 2014; 60(4):483-9. PubMed ID: 25807827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introductory overview of purinergic signalling.
    Burnstock G
    Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release and interconversion of P2 receptor agonists by human osteoblast-like cells.
    Buckley KA; Golding SL; Rice JM; Dillon JP; Gallagher JA
    FASEB J; 2003 Aug; 17(11):1401-10. PubMed ID: 12890693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.